Akut limfoid leukémia (ALL): vizsgálatok itt: Kína
169 trials · From ClinicalTrials.gov, checked 2026. november 16.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleClinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia
- Where
- Beijing, Chengdu, Chongqing, Guangzhou, Hangzhou, Sanhe, Shanghai, Tianjin, Wuhan, Xuzhou, Zhengzhou
- Életkor
- 18 év to 65 év
- People
- 100
- Run by
- Juventas Cell Therapy Ltd.
See details and how to joinNCT04684147 - 2. fázisTaking peopleEfficacy of Acute Lymphoblastic Leukemia-Based Therapy in Treating Patients With Acute Leukemia of Ambiguous Lineage
- Where
- Tianjin
- Életkor
- 14 év and over
- People
- 50
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT04440267 - 1/2. fázisTaking peopleFourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia (PMBCL/CNS-BCL).
- Where
- Beijing
- Életkor
- 2 év to 90 év
- People
- 75
- Run by
- Essen Biotech
See details and how to joinNCT06213636 - 2. fázisTaking peopleEffectiveness and Safety of Blinatumomab and Donor Lymphocyte Infusion in Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation for High-risk Ph Negative B Cell Acute Lymphoblastic Leukemia
- Where
- Hangzhou
- Életkor
- 14 év to 65 év
- People
- 31
- Run by
- First Affiliated Hospital of Zhejiang University
See details and how to joinNCT07105579 - 1. fázisTaking peopleCD180 CART for Relapsed or Refractory CD180 Positive Hematologic Malignancies
- Where
- Tianjin
- Életkor
- 18 év to 70 év
- People
- 12
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07106749 - 2. fázisTaking peoplePediatric-inspired Regimen Combined With Venetoclax for Adolescent and Adult Patients With de Novo Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
- Where
- Tianjin
- Életkor
- 14 év to 60 év
- People
- 100
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT05660473 - No phaseNot yet taking people in KínaEx Vivo T-Cell-Depleted Haploidentical Transplantation Bridging With Chimeric Antigen Receptor T-cell Therapy and Prophylactic Memory T Cell Infusion for Acute Leukemia
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 18
- Run by
- Ruijin Hospital
See details and how to joinNCT07087847 - 1/2. fázisTaking peopleCD19 CAR-T Cell Infusion as Consolidation Therapy in Adolescent and Adult Patients With Acute B-ALL Ineligible for Allogeneic HSCT: A Clinical Study
- Where
- Guangzhou
- Életkor
- 14 év to 80 év
- People
- 30
- Run by
- Zhujiang Hospital
See details and how to joinNCT07072494 - 2/3. fázisTaking peopleMulticenter Study of Combined Chemotherapy and Transplantation for Adult ALL
- Where
- Taiyuan
- Életkor
- 18 év to 60 év
- People
- 50
- Run by
- Shanxi Bethune Hospital
See details and how to joinNCT07059156 - 1. fázisNot yet taking people in KínaA Clinical Study Exploring Universal CAR-T Cell in Patients With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 36
- Run by
- Shanghai Tongji Hospital, Tongji University School of Medicine
See details and how to joinNCT07043218 - 1/2. fázisTaking peopleBCOR and ZC3H12 Genes Knock-out CD19-targeting CAR-T Cell Therapy in r/r B-ALL
- Where
- Beijing
- Életkor
- 18 év to 70 év
- People
- 30
- Run by
- Chinese PLA General Hospital
See details and how to joinNCT07008885 - No phaseTaking peopleThe Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies
- Where
- Taiyuan
- Életkor
- 14 év to 75 év
- People
- 50
- Run by
- Hebei Senlang Biotechnology Inc., Ltd.
See details and how to joinNCT05618041 - No phaseTaking peopleJY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia
- Where
- Guangzhou
- Életkor
- 12 év to 75 év
- People
- 20
- Run by
- Affiliated Hospital of Guangdong Medical University
See details and how to joinNCT06940960 - 2. fázisTaking peopleVenetoclax + Azacytidine for Newly Diagnosed ETP-like ALL and T-ALL With Myeloid Mutations
- Where
- Suzhou
- Életkor
- 14 év and over
- People
- 32
- Run by
- yuejun Liu
See details and how to joinNCT07012447 - No phaseTaking peopleIntravenous Autologous CD19 CAR-T Cells for R/ R MM, B-ALL, and B-Cell Lymphoma
- Where
- Hefei
- Életkor
- 3 év and over
- People
- 18
- Run by
- Anhui Provincial Hospital
See details and how to joinNCT06961669 - No phaseTaking peopleJY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia
- Where
- Zhengzhou
- Életkor
- 18 év to 75 év
- People
- 20
- Run by
- Shenzhen Genocury Biotech Co., Ltd.
See details and how to joinNCT06890065 - 2. fázisTaking peopleDemethylating Agents Combined With Venetoclax for High-risk T-cell Lymphoblastic Lymphoma/Leukemia Post-Transplant Relapse Prevention
- Where
- Shanghai
- Életkor
- 14 év to 55 év
- People
- 59
- Run by
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06686108 - No phaseNot yet taking people in KínaJY231(JY231) Injection for the Treatment of Relapsed or Refractory B-Cell Leukemia
- Where
- Hangzhou
- Életkor
- 18 év to 75 év
- People
- 24
- Run by
- He Huang
See details and how to joinNCT06902025 - No phaseTaking peopleBridging Allogeneic Hematopoietic Stem Cell Transplantation or Not After CD19 CAR - T (S1904) Cell Therapy for r/r B-cell Acute Lymphoblastic Leukemia
- Where
- Beijing
- Életkor
- 12 év to 65 év
- People
- 130
- Run by
- Peking University People's Hospital
See details and how to joinNCT06581081 - 1. fázisTaking peopleThiotepa, Cyclophosphamide, Clarithromycin and Cytarabine
- Where
- Zhuhai
- Életkor
- 18 év to 65 év
- People
- 28
- Run by
- Fifth Affiliated Hospital, Sun Yat-Sen University
See details and how to joinNCT06060782 - 2. fázisNot yet taking people in KínaEffectiveness and Safety of InO±DLI for Relapsed B-ALL/LBL After Allo-HSCT
- Where
- Hangzhou
- Életkor
- 14 év to 65 év
- People
- 23
- Run by
- First Affiliated Hospital of Zhejiang University
See details and how to joinNCT06861348 - 2. fázisTaking peopleA Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditioning Regimen for Adult ALL
- Where
- Zhengzhou
- Életkor
- 18 év to 65 év
- People
- 170
- Run by
- The First Affiliated Hospital of Zhengzhou University
See details and how to joinNCT06557161 - 2. fázisTaking peopleA Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALL
- Where
- Zhengzhou
- Életkor
- 1 év to 17 év
- People
- 276
- Run by
- The First Affiliated Hospital of Zhengzhou University
See details and how to joinNCT06559345 - 2. fázisTaking peopleA Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALL
- Where
- Zhengzhou
- Életkor
- 1 év to 17 év
- People
- 170
- Run by
- The First Affiliated Hospital of Zhengzhou University
See details and how to joinNCT06564493 - 2. fázisTaking peopleA Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Adult ALL
- Where
- Zhengzhou
- Életkor
- 18 év to 65 év
- People
- 276
- Run by
- The First Affiliated Hospital of Zhengzhou University
See details and how to joinNCT06564545